Lactic Acid

Lactic Acid

SCHEMBL2585781

CC(O)C(=O)O.[K+].[OH-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lactic Acid SCHEMBL19463957 0.92 — —
Lactic Acid SCHEMBL28135832 0.92 — —
Lactic Acid SCHEMBL27960791 0.92 TP53 (0.85) —
Lactic Acid SCHEMBL4821907 0.92 TP53 (0.85) —
Lactic Acid SCHEMBL19463679 0.92 — —
Lactic Acid SCHEMBL31230586 0.92 TP53 (0.85) —
Lactic Acid SCHEMBL27489945 0.92 — —
Lactic Acid SCHEMBL28707219 0.92 TP53 (0.85) —
Lactic Acid SCHEMBL107061 0.92 — —
Lactic Acid SCHEMBL5189465 0.92 TP53 (1.00) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048279-B2 Method and apparatus for electrocoagulation of liquids POWELL SCOTT WADE 2011-11-01 — — US claimed
US-20090173638-A1 METHOD AND APPARATUS FOR ELECTROCOAGULATION OF LIQUIDS POWELL SCOTT WADE 2009-07-09 — — US claimed
EP-3442489-B1 SUNSCREEN FORMULATIONS COMPRISING AN OLEOSOME SUSPENSION AND AN ACIDIC BUFFERING SYSTEM BOTANECO INC (CA) 2022-07-06 — — EP disclosed
CN-109789205-A Anti- PD-1(CD279) antibody 艾伯维生物制药股份有限公司 2019-05-21 — — CN disclosed
US-20190105248-A1 SUNSCREEN FORMULATIONS COMPRISING AN OLEOSOME SUSPENSION AND AN ACIDIC BUFFERING SYSTEM BOTANECO INC. (CA) 2019-04-11 — — US disclosed
CN-109476750-A anti-CD 40 antibodies and uses thereof 艾伯维生物制药股份有限公司 2019-03-15 — — CN disclosed
EP-3442489-A1 SUNSCREEN FORMULATIONS COMPRISING AN OLEOSOME SUSPENSION AND AN ACIDIC BUFFERING SYSTEM Botaneco Inc. (CA) 2019-02-20 — — EP disclosed
WO-2017177334-A1 SUNSCREEN FORMULATIONS COMPRISING AN OLEOSOME SUSPENSION AND AN ACIDIC BUFFERING SYSTEM BOTANECO INC. (CA) 2017-10-19 — — WO disclosed
CN-105399622-B A kind of method of use heavy constituent production of lactic acid potassium lactate 武汉三江航天固德生物科技有限公司 2017-09-19 — — CN disclosed
CN-105399622-A Method for producing potassium lactate from heavy-component lactic acid WUHAN SANJIANG SPACE GOOD BIOTECH CO LTD 2016-03-16 — — CN disclosed
US-8048279-B2 Method and apparatus for electrocoagulation of liquids POWELL SCOTT WADE 2011-11-01 — — US disclosed
US-20090173638-A1 METHOD AND APPARATUS FOR ELECTROCOAGULATION OF LIQUIDS POWELL SCOTT WADE 2009-07-09 — — US disclosed
Send feedback